Since the beginning of China's 14th Five-Year Plan period (2021-2025), the country has registered a net increase of nearly 20 million enterprises and approximately 34 million self-employed households, according to the State Administration for Market Regulation. The pharmaceutical industry has grown to become the second largest globally. From January to July 2025, China saw the establishment of 36,133 new foreign-invested enterprises, marking a 14.1% year-on-year increase. During this period, the actual utilization of foreign capital reached 467.34 billion yuan ($65.09 billion), as reported by the Ministry of Commerce. These developments reflect major progress in China's market regulation and quality growth throughout the 14th Five-Year Plan.